Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/r + Etravirine Substitution for Enfuvirtide in HIV
NCT00460746Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etravirine, darunavir in human immunodeficiency virus infection (HIV), sponsored by Johnson & Johnson. Started May 2007; status: completed.
02
Drugs
etravirinedarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00460746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460746.